Specialised semiconductors for devices that connect to the nervous system.
Alumni Ventures
Activity from announced rounds
Alumni Ventures co-invests in startup rounds alongside an established lead investor. Its principal focus is pre-seed through Series B, with typical investments of $1 million to $3 million.
The firm generally joins on the lead investor’s terms, does not take a board seat and commits after a lead is secured. Founders do not need an alumni connection to qualify. This makes it a potential syndicate participant for a company that already has the core terms and leadership of its round in place.
Its platform team works on introductions to customers, hires and subsequent investors. Founders can request help through their investment team or the AVP Hub, including access to the firm’s alumni networks and commercial resources.
Sources
- Rounds participated in
- 13
- Confirmed lead rounds
- 0 11 roles undisclosed
- New companies
- 13 First participation on record · 0 follow-on
- Funding in participating rounds
- $373.5M 13 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
13 in this selectionEvvy combines at-home vaginal microbiome testing with clinician-reviewed results, personalized next steps and optional treatment and coaching for women’s health.
Technology-enabled primary care model serving rural communities in the Southeast US
AI platform coordinating clinical and administrative workflows for musculoskeletal care providers
Robotic AI ultrasound platform automating vascular imaging for dialysis patients
Simulates how procedural devices perform across virtual patients before clinical deployment
Builds closed-loop in-ear earbuds that capture physiological signals and deliver real-time AI-guided sleep interventions
Automates curation and enrichment of real-world clinical data for pharmaceutical and life sciences research
Analyzes healthcare transactions in real time to identify payer behavior patterns and recover provider revenue
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
Develops implantable Brain-Computer Interfaces (iBCIs) for neurological disorders
Provides AI-powered olfaction technology for fragrance, healthcare, and public safety sectors
Provides AI-powered commercial intelligence for Life Sciences organizations